Investment Rating - The report does not explicitly provide an investment rating for the industry. Core Insights - The Politburo study session on January 31, 2026, emphasized the need for forward-looking planning and development of future industries, focusing on leveraging comparative advantages and systematic cultivation of key technologies [1][8]. - The policy evolution indicates a shift from initial directional guidance to a more actionable framework for industrial organization, enhancing predictability and stability for long-term investments in the technology sector [2][9]. - The development of future industries is centered around six major directions, with a common foundation of "new infrastructure + high-end manufacturing capabilities," highlighting the importance of engineering, scalability, and regulatory frameworks [3][10]. Summary by Sections Future Industry Development - The meeting outlined principles such as "industry poses the questions, science provides the answers," which will guide the systematic layout of basic research and the transformation of scientific achievements into practical applications [1][8]. - The focus on "gradient cultivation" suggests a structured approach to industrial growth, allowing for early-stage uncertainties while promoting comprehensive support across the entire value chain [2][9]. Key Areas of Focus - The report identifies critical areas such as quantum computing, biomanufacturing, hydrogen energy, brain-computer interfaces, embodied intelligence, and 6G technology as essential for future industrial competitiveness [3][10]. - Embodied intelligence is highlighted as a significant driver of spillover effects across the technology supply chain, integrating various components such as sensors, actuators, and AI systems [4][11]. Governance and Standards - The emphasis on governance and standards is seen as an accelerator for industrialization, providing a clear framework for compliance and risk management, which is crucial for attracting investment and fostering innovation [5][13]. - The report suggests that clearer standards will facilitate product definition and market access, making commercialization pathways more predictable [13].

Investment Rating - The report maintains an "Outperform" rating for Sunny Optical Technology [2][10][17] Core Insights - Sunny Optical is expected to achieve attributable net profit of RMB 45.89–47.24 billion in 2025, representing a year-on-year increase of 70% to 75%, significantly above Bloomberg consensus of RMB 35.39 billion. This upside is primarily driven by a one-off investment gain of approximately RMB 9.19 billion from an equity transfer for a stake in Goertek Optics. Excluding this non-recurring item, the core attributable net profit is estimated to be RMB 36.7–38.05 billion, supported by the ongoing premiumization of smartphone camera specifications [3][13] - The company continues to benefit from the upgrade of camera specifications in flagship and mid-to-high-end smartphones, which is expected to drive the average selling price (ASP) and gross margin for handset lenses and camera modules [4][14] Summary by Relevant Sections Handsets - Despite ongoing cost pressures from rising memory prices, the trend towards optical upgrades in smartphones remains intact. The company is well-positioned to benefit from the adoption of higher-value products such as variable aperture and periscope cameras, which will drive ASP and margin expansion [4][14] Automotive - The adoption of intelligent driving technologies is expected to significantly boost the company's automotive lens and module businesses. The average number of cameras per vehicle is projected to increase, with high-end vehicles already equipped with around 12 cameras. This trend is anticipated to accelerate growth in the automotive segment [5][15] XR & IoT - The company maintains its leading market share in imaging modules for smart glasses, with strong growth in revenue from handheld imaging devices. The rapid expansion of AI and AR glasses is expected to become a key growth driver in the coming years [6][16] Valuation - The estimated EPS for 2025-2027 is revised to RMB 4.23, 3.86, and 4.19 respectively. Based on a P/E ratio of 19.6x for 2026, the target price is set at HKD 85.24, maintaining the "Outperform" rating [6][17]

[Table_Title] 研究报告 Research Report 2 Feb 2026 康哲药业 China Medical System Holdings (867 HK) [Table_yemei1] 热点速评 Flash Analysis [Table_summary] (Please see APPENDIX 1 for English summary) 事件 1 月 30 日，康哲药业子公司德镁医药，获得中国国家药品监督管理局（NMPA）批准磷酸芦可替尼乳膏新药上市许 可申请，用于治疗 12 岁及以上儿童和成人患者伴面部受累的非节段型白癜风。芦可替尼乳膏（Opzelura®）是 Incyte 开发的选择性 JAK1/JAK2 抑制剂芦可替尼制成的一种创新型乳膏。2022 年 12 月，德镁医药与 Incyte 就芦可 替尼乳膏订立许可协议，获得在中国大陆、香港特别行政区、澳门特别行政区、台湾地区及东南亚十一国研发、 注册及商业化产品的独家许可权利，以及生产产品的非独家许可权利。 重磅品种芦可替尼获批上市，未来增长可期 Blockbuster Drug Ruxolitinib Cream Appr ...

Investment Rating - The report suggests a positive outlook for gas turbine manufacturers and related supply chain companies, recommending to pay attention to companies such as GE Vernova, Siemens Energy, Mitsubishi Heavy Industries, Caterpillar, and Howmet [5][12]. Core Insights - The approval of a 7.65 GW gas-fired power generation air permit for Pacifico Energy marks the largest power generation emission permit in U.S. history, indicating significant growth potential in the energy sector, particularly for data centers [1][7]. - U.S. electricity demand is projected to grow at an average rate of 5.7% annually over the next five years, with peak demand increasing by approximately 166 GW, largely driven by data centers [2][8]. - Texas has emerged as a hotspot for data centers, with ERCOT forecasting a compound annual growth rate (CAGR) of 10.1% for peak load over the next five years, significantly higher than the national average [3][9]. - The trend of data centers building their own off-grid power plants is solidifying, driven by the need for reliable baseload energy sources, with natural gas generation currently being the optimal choice [4][10]. - Policy support at both federal and state levels is encouraging the establishment of self-built power plants for data centers, which is expected to further boost the gas turbine equipment market [5][11]. Summary by Sections Section 1: Emission Permit Approval - Pacifico Energy's GW Ranch project in Texas has received a 7.65 GW gas-fired power generation air permit, the largest in U.S. history, with plans for additional energy sources including battery storage and solar PV [1][7]. Section 2: Electricity Demand Forecast - The demand for electricity in the U.S. is expected to increase by 32% by 2030, with data centers accounting for about 55% of the forecasted growth in utility load projections over the next five years [2][8]. Section 3: Data Center Growth in Texas - Texas is experiencing a surge in data center capacity, with interconnection queues totaling approximately 160-180 GW, reflecting a nearly 300% increase in just one year [3][9]. Section 4: Energy Source Trends - Data centers are increasingly requiring more baseload energy sources, leading to a trend of self-built off-grid power plants, with natural gas being the preferred energy source due to its abundance and low cost [4][10]. Section 5: Policy Support and Market Outlook - Recent policy changes are favoring the development of self-built power plants for data centers, which is expected to enhance the market for gas turbine equipment as demand for baseload generation grows [5][11].

[Table_Title] 研究报告 Research Report 2 Feb 2026 中国半导体 China (Overseas) Semiconductor FY4Q25 全球科技业绩快报：意法半导体 FY4Q25 Global Semiconductor Earnings Snapshot: STMicroelectronics 姚书桥 Barney Yao barney.sq.yao@htisec.com [Table_yemei1] 热点速评 Flash Analysis [Table_summary] (Please see APPENDIX 1 for English summary) 事件 意法半导体 4Q25 业绩 mix：意法半导体公布的 4Q25 业绩整体 mix，收入为 33.3 亿美元（市场预期 33.0 亿美元）， 超出指引中值。毛利率为 35.2%，优于市场预期的 35.0%±200 bps 区间中值，主要得益于产品组合优化。然而，因包 含一笔 1.63 亿美元的一次性非现金税务支出影响，摊薄后 EPS 录得亏损；若不计此项，non-GAAP 口径下摊薄 EPS 为 $0.1 ...

Investment Rating - The report does not explicitly provide an investment rating for the industry or specific companies involved in the internet-based first consultation pilot in Beijing. Core Insights - The pilot program for internet-based first consultations in Beijing is expected to have landmark significance for nationwide policy expansion, aiming to relieve offline clinical pressure and extend quality medical resources digitally across China [2][6]. - The policy is anticipated to drive online traffic growth and accelerate prescription outflow, particularly in specialties suitable for remote diagnosis such as dermatology, mental health, and nutrition [7][8]. - The integration of "consultation-examination-diagnosis-medication" services is facilitated by this policy, potentially streamlining patient journeys and reducing transportation costs [8]. Summary by Sections Event - On January 31, 2026, the National Health Commission approved a pilot for internet-based first consultations in pediatric specialties in Beijing, running from January to December 2026 [1][5]. Commentary - The pilot aims to address the medical needs of out-of-town patients and relieve non-capital functions in Beijing, with the potential to serve as a reference for similar initiatives nationwide [2][6]. - If the scope of internet-based first consultations expands, it could lead to significant growth in online consultations and related health product sales [7]. - Leading companies like Alibaba Health and JD Health are expected to benefit from the expansion of this policy [8].

Investment Rating - The report rates multiple companies in the consumer staples sector as "Outperform," including Guizhou Moutai, Wuliangye, and Yili [1]. Core Insights - The consumer staples industry in January 2026 shows a recovery in basic demand while hedonic consumption remains under pressure, indicating a divergence in performance across different segments [3][29]. - Among the eight key consumer industries tracked, four are experiencing positive growth (condiments, frozen food, soft drinks, and catering), while four are facing declines (high-end and above Baijiu, mass-market Baijiu, dairy products, and beer) [29]. Summary by Segment Baijiu (High-end and Above) - In January, the revenue for high-end Baijiu reached 47 billion yuan, a year-on-year decline of 14.0%. The price pressure is significant, with expectations of over a 10% price drop throughout the year due to high inventory levels [11]. Baijiu (Mass-market and Below) - The mass-market Baijiu segment generated 22.9 billion yuan in January, down 3.0% year-on-year. Despite the decline, the segment shows resilience due to rigid demand and adaptability to consumption scenarios [13]. Beer - The beer industry reported revenues of 17 billion yuan in January, a decrease of 7.1% year-on-year. The demand was affected by adverse weather and the delayed Spring Festival, leading to a cautious inventory approach by distributors [15]. Condiments - The condiment sector achieved revenues of 46.9 billion yuan in January, reflecting a year-on-year growth of 3.5%. The recovery in the catering channel and increased demand from small and medium-sized businesses are key drivers [17]. Dairy Products - The dairy sector's revenue was 43.5 billion yuan in January, down 3.3% year-on-year. The demand remains under pressure, but a potential recovery is anticipated in the coming months due to low base effects [19]. Frozen Food - The frozen food segment saw revenues of 14.99 billion yuan in January, with a year-on-year increase of 8%. The demand is supported by pre-Spring Festival stocking and favorable weather conditions [21]. Soft Drinks - The soft drink industry generated 96.2 billion yuan in January, with a modest growth of 1.1% year-on-year. Increased promotional activities indicate heightened market competition [24]. Catering - The catering sector reported revenues of 16.2 billion yuan in January, up 2.5% year-on-year. The demand is gradually improving, particularly in small and medium-sized restaurants [26].

Investment Rating - The report assigns an "Outperform" rating to multiple companies in the discretionary consumption sector, including Nike, Li Ning, Midea Group, JD Group, Haier Smart Home, Gree Electric Appliances, Anta Sports, and many others [1]. Core Insights - The discretionary consumption sector has experienced a significant pullback due to the hawkish stance of the Federal Reserve, leading to a decline in global asset prices [4][13]. - The report highlights that the domestic sportswear sector outperformed other segments, while luxury goods and cosmetics faced notable declines [4][13]. - The report provides a detailed analysis of the performance of various sub-sectors, indicating that gold and jewelry, overseas cosmetics, and snacks have shown resilience compared to the MSCI China index [4][11]. Summary by Relevant Sections Weekly Performance Review - The domestic sportswear sector increased by 0.6%, while other sectors such as credit cards, U.S. hotels, and retail saw declines ranging from -0.4% to -5.8% [4][13]. - The report notes that the gold and jewelry sector has outperformed the MSCI China index, with a monthly increase of 14.8% [4][13]. Sector Analysis - The domestic sportswear sector's growth is attributed to increased demand for warm clothing due to colder weather and positive media coverage of brands like Bosideng [15]. - The credit card sector saw mixed results, with Mastercard rising by 2.7% while Visa and American Express declined [15]. - The retail sector's performance was driven by specific companies like China Resources Mixc Lifestyle, which saw a 10.8% increase due to favorable policies [15]. Valuation Analysis - The report indicates that the expected PE ratios for various sectors in 2025 are below their historical averages, suggesting potential investment opportunities [11][18]. - For instance, the expected PE for the domestic sportswear sector is 13.4 times, which is 70% of its past five-year average [18]. Conclusion - Overall, the report emphasizes the impact of macroeconomic factors on the discretionary consumption sector and identifies specific companies and sub-sectors that may present investment opportunities amidst the current market volatility [4][11][18].

Investment Rating - The report maintains an "Outperform" rating for multiple companies in the healthcare sector, including BeiGene, JD Health, WuXi Biologics, and others, while China National Pharmaceutical Group is rated "Neutral" [1]. Core Insights - The Hong Kong healthcare sector experienced a broad-based correction due to capital pressures, with pharmaceutical distribution remaining relatively stable [4][28]. - The Hang Seng Healthcare Index fell by 3.0% this week, underperforming the Hang Seng Index by 5.4 percentage points, but has gained 8.6% year-to-date, outperforming the Hang Seng Index by 1.7 percentage points [14][27]. - The top five gainers in the sector included Leads Biolabs-B (+19.3%), Sihuan Pharmaceutical (+17.9%), and Tigermed (+7.6%), while the bottom five decliners included Medlive Technology (-16.2%) and Laekna-B (-14.1%) [4][29]. Summary by Sections Market Performance - The report indicates that various sub-sectors within the Hong Kong healthcare market experienced declines, with pharmaceutical distribution down by 0.3%, internet healthcare down by 2.1%, and medical devices down by 5.0% [4][28]. Company Highlights - Rongchang Biopharmaceutical announced a revenue forecast of 3.25 billion yuan for 2025, representing an 89% year-on-year increase, and reported a turnaround to profitability [11]. - A collaboration agreement was signed between CSPC Pharmaceutical and AstraZeneca, involving a total payment of $18.5 billion for the licensing of GLP-1 long-acting assets [11]. - AstraZeneca plans to invest $15 billion in China by 2030, focusing on expanding drug manufacturing and R&D capabilities [12]. - Kangzheng Pharmaceutical's lebrikizumab cream has been approved for the treatment of non-segmental vitiligo in patients aged 12 and older [12]. Regulatory Developments - The National Health Commission approved a pilot program for internet-based first consultations in Beijing, which is expected to accelerate prescription outflow and improve access to healthcare services [13].

Investment Focus - The report emphasizes a balanced allocation between technology and value sectors, focusing on market structure rather than short-term index fluctuations [1][11] - Recent market movements show a stronger rebound in value sectors compared to high-tech, with increased expectations for policies supporting the real estate sector [1][12] - Rising commodity prices and stabilization in certain product prices are aiding valuation recovery in undervalued sectors like real estate and baijiu [1][12] Market Outlook - The report anticipates stabilization and upward movement in Chinese equities (A-shares and Hong Kong stocks) leading into the Lunar New Year, driven by domestic fundamentals and liquidity conditions [2][13] - A series of political and economic catalysts, including local and national meetings and the rollout of the 15th Five-Year Plan, are expected to enhance market sentiment [2][13] Investment Strategy - The report suggests positioning for the Lunar New Year "red packet" rally by focusing on industries benefiting from holiday effects and macroeconomic catalysts [2][14] - Key areas of focus include AI applications, high-quality tech manufacturing, and future industries such as defense and domestic chip production [2][14] Sector Analysis - Non-bank financials, particularly brokers and insurers, are expected to recover from previous outflows due to their strong fundamentals [3][19] - The holiday consumption chain, including sectors like gaming, food and beverage, and travel, is highlighted as a potential growth area [3][19] - Hong Kong dividend assets with earnings leverage, such as real estate and chemicals, are also noted for their potential upside following policy support [3][19] Liquidity Data - A-share ETF flows show a divergence, with broad-based ETFs experiencing significant outflows while sector-specific ETFs saw inflows, particularly in metals and chemicals [4][16] - In Hong Kong, short-selling activity has returned to historical averages, with notable inflows into energy and property sectors [5][17]